Evidence map›Paper›PMID 27123694›Full record

ArticleAutophagy2016

Prosurvival AMBRA1 turns into a proapoptotic BH3-like protein during mitochondrial apoptosis.

Flavie Strappazzon, Anthea Di Rita, Valentina Cianfanelli, Melania D'Orazio, Francesca Nazio, Gian Maria Fimia, Francesco Cecconi

Abstract read
In one paragraph

Article in Autophagy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Autophagy · 2023
    Article
  9. Article
  10. Article
  11. Ambra1 in cancer: implications for clinical oncology.Apoptosis : an international journal on programmed cell death · 2022
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Flavie Strappazzona IRCCS Fondazione Santa Lucia , Rome , Italy.
Anthea Di Ritaa IRCCS Fondazione Santa Lucia , Rome , Italy.
Valentina Cianfanellic Unit of Cell Stress and Survival, Danish Cancer Society Research Center , Copenhagen , Denmark.
Melania D'Oraziob Department of Biology , University of Rome Tor Vergata , Rome , Italy.
Francesca Nazioa IRCCS Fondazione Santa Lucia , Rome , Italy.
Gian Maria Fimiad Department of Biological and Environmental Sciences and Technologies (DiSTeBA) , University of Salento, Lecce , Italy.
Francesco Cecconia IRCCS Fondazione Santa Lucia , Rome , Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy and apoptosis are 2 stress-response mechanisms that are closely interconnected. However, the molecular interplays between these 2 pathways remain to be clarified. Here we report that the crucial proautophagic factor AMBRA1 can act as a positive mediator of mitochondrial apoptosis. Indeed, we show that, in a proapoptotic positive feedback loop, the C-terminal part of AMBRA1, generated by CASP/CASPASE cleavage upon apoptosis induction, inhibits the antiapoptotic factor BCL2 by a direct binding through its BH3-like domain. The mitochondrial AMBRA1-BCL2 complex is thus at the crossroad between autophagy and cell death and may represent a novel target in development of therapeutic approaches in clinical diseases.

Indexed as

ApoptosisAdaptor Proteins, Signal TransducingAmino Acid MotifsAmino Acid SequenceCell SurvivalHEK293 CellsHeLa CellsHumansMitochondriaMitochondrial MembranesModels, BiologicalPermeabilityProtein BindingProto-Oncogene Proteins c-bcl-2Adaptor Proteins, Signal TransducingProto-Oncogene Proteins c-bcl-2AMBRA1apoptosisautophagyBCL2BH3 domain

Identifiers

PMID27123694
PMCPMC4922440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.